Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is the major cause of cancer mortality worldwide. Though multidisciplinary therapies have been widely used for NSCLC, its overall prognosis remains very poor, presumably owing to lack of effective prognostic biomarkers. SMAD, a well-known transcription factor, play...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Zhenguo, Yang, Yuting, Qing, Cheng, Hu, Zhiguo, Huang, Yiming, Zhou, Chaoqi, Li, Dan, Jiang, Yanxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220383/
https://www.ncbi.nlm.nih.gov/pubmed/32150102
http://dx.doi.org/10.1097/MD.0000000000019451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220383/
https://www.ncbi.nlm.nih.gov/pubmed/32150102
http://dx.doi.org/10.1097/MD.0000000000019451

Ejemplares similares